Data / Form D filings / ND Acquisitions Corp.
ND Acquisitions Corp.: Form D filings
ND Acquisitions Corp., a pharmaceuticals company in Nashville, TN, filed 9 Form D notices with the SEC between 2009 and 2015. The latest, on March 18, 2015, reports $3.8 million sold of a $3.8 million offering to 7 investors.
Find out what ND Acquisitions Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5215 LINBAR DRIVE, SUITE 210, Nashville, TN, 37211
- Phone
- (615) 947-2966
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1464225
The full lists. Form D filings in Tennessee: 543 rows, $27.15, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2015 | New notice | $3,849,424 | $3,849,424 | $0 | 7 | Mar 10, 2015 | sec.gov |
| Jul 2, 2014 | Amendment | $11,031,858 | $11,031,858 | $0 | 12 | Jun 11, 2013 | sec.gov |
| Jun 28, 2013 | New notice | $10,000,000 | $8,531,859 | $1,468,141 | 12 | Jun 11, 2013 | sec.gov |
| Jan 24, 2013 | New notice | $1,947,385 | $1,947,385 | $0 | 10 | Jan 16, 2013 | sec.gov |
| Jul 19, 2012 | New notice | $2,000,000 | $2,000,000 | $0 | 11 | Jul 13, 2012 | sec.gov |
| Sep 22, 2011 | New notice | $12,224,529 | $12,224,529 | $0 | 13 | Sep 9, 2011 | sec.gov |
| Mar 10, 2011 | New notice | $5,000,000 | $5,000,000 | $0 | 5 | Feb 25, 2011 | sec.gov |
| Oct 5, 2010 | New notice | $1,501,115 | $1,501,115 | $0 | 7 | Sep 27, 2010 | sec.gov |
| May 21, 2009 | New notice | $5,473,606 | $5,473,606 | $0 | 6 | May 8, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dennis C. Bottorff | Director | |
| C. Daniel Haron | Executive Officer, Director | |
| Chris Daniel Maness | Executive Officer | |
| Linwood A. Lacy, Jr. | Director | |
| Kenneth M. Krakaur | Director | |
| David A. Kaufman | Director | |
| Mary Daniel Howard | Executive Officer |
Every Form D from the week of Mar 16, 2015 · All recent filings in Tennessee · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ND Acquisitions Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.